Velan Capital Investment Management LP - Q3 2023 holdings

$124 Million is the total value of Velan Capital Investment Management LP's 30 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 38.7% .

 Value Shares↓ Weighting
BuyALIMERA SCIENCES INC$42,186,452
+770.5%
13,608,533
+720.0%
34.02%
+656.1%
PRAX  PRAXIS PRECISION MEDICINES I$8,866,350
+48.7%
5,185,0000.0%7.15%
+29.1%
 JASPER THERAPEUTICS INC$7,586,797
-48.9%
11,219,0360.0%6.12%
-55.6%
HRTX BuyHERON THERAPEUTICS INC$7,196,346
+37.9%
6,986,744
+55.3%
5.80%
+19.7%
ADMA SellADMA BIOLOGICS INC$6,215,238
-38.2%
1,736,100
-36.3%
5.01%
-46.3%
TELA  TELA BIO INC$5,968,696
-21.0%
746,0870.0%4.81%
-31.4%
QIPT BuyQUIPT HOME MEDICAL CORP$5,599,000
+8.1%
1,100,000
+13.4%
4.52%
-6.1%
LNTH SellLANTHEUS HLDGS INC$5,211,000
-37.9%
75,000
-25.0%
4.20%
-46.1%
OPTN  OPTINOSE INC$4,424,1390.0%3,596,8610.0%3.57%
-13.1%
 MOONLAKE IMMUNOTHERAPEUTICSclass a ord$3,152,100
+11.8%
55,3000.0%2.54%
-2.9%
INSP NewINSPIRE MED SYS INC$3,036,13215,300
+100.0%
2.45%
IMGN  IMMUNOGEN INC$3,007,365
-15.9%
189,5000.0%2.43%
-26.9%
NSPR  INSPIREMD INC$2,956,175
+30.3%
904,0290.0%2.38%
+13.1%
GOSS NewGOSSAMER BIO INC$2,552,6453,065,136
+100.0%
2.06%
CABA SellCABALETTA BIO INC$2,283,000
-29.3%
150,000
-40.0%
1.84%
-38.6%
APLS NewAPELLIS PHARMACEUTICALS INC$1,902,00050,000
+100.0%
1.53%
GERN  GERON CORP$1,650,420
-34.0%
778,5000.0%1.33%
-42.6%
THC SellTENET HEALTHCARE CORP$1,643,099
-61.1%
24,937
-52.0%
1.32%
-66.2%
 ICOSAVAX INC$1,244,883
-22.0%
160,6300.0%1.00%
-32.2%
NewASLAN PHARMACEUTICALS LTDspon ads new$1,175,000625,000
+100.0%
0.95%
IOVA NewIOVANCE BIOTHERAPEUTICS INCcall$1,137,500250,000
+100.0%
0.92%
ANNX  ANNEXON INC$1,085,001
-33.0%
459,7460.0%0.88%
-41.8%
EDSA  EDESA BIOTECH INC$809,981
-22.1%
1,281,6150.0%0.65%
-32.3%
CGEM BuyCULLINAN ONCOLOGY INC$678,750
+26.2%
75,000
+50.0%
0.55%
+9.4%
IFRX  INFLARX NV$596,000
-33.2%
200,0000.0%0.48%
-41.9%
RZLT  REZOLUTE INC$528,000
-33.3%
400,0000.0%0.43%
-42.0%
QIPT  QUIPT HOME MEDICAL CORPcall$509,000
-4.7%
100,0000.0%0.41%
-17.1%
INBX  INHIBRX INC$458,750
-29.3%
25,0000.0%0.37%
-38.6%
ELEV  ELEVATION ONCOLOGY INC$329,510
-56.4%
497,2990.0%0.27%
-62.1%
ExitAIRSCULPT TECHNOLOGIES INCcall$0-75,000
-100.0%
-0.60%
AVDL ExitAVADEL PHARMACEUTICALS PLCsponsored adr$0-100,000
-100.0%
-1.53%
IOVA ExitIOVANCE BIOTHERAPEUTICS INC$0-240,000
-100.0%
-1.57%
ETNB Exit89BIO INC$0-95,000
-100.0%
-1.67%
CTLT ExitCATALENT INC$0-50,000
-100.0%
-2.01%
PNT ExitPOINT BIOPHARMA GLOBAL INC$0-342,936
-100.0%
-2.88%
GRTX ExitGALERA THERAPEUTICS INC$0-1,000,000
-100.0%
-2.90%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LANTHEUS HLDGS INC8Q3 202318.0%
ADMA BIOLOGICS INC8Q3 202313.7%
JASPER THERAPEUTICS INC8Q3 202317.8%
TELA BIO INC8Q3 20237.6%
REZOLUTE INC8Q3 20231.3%
OPTINOSE INC7Q3 20237.9%
IMMUNOCORE HLDGS PLC6Q1 202313.7%
ALIMERA SCIENCES INC6Q3 202334.0%
QUIPT HOME MEDICAL CORP6Q3 20234.8%
SONIDA SENIOR LIVING INC6Q1 20232.5%

View Velan Capital Investment Management LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
42024-02-09
SC 13D/A2024-02-09
SC 13G/A2024-01-29
13F-HR2023-11-13
42023-10-04
42023-08-17
SC 13D/A2023-08-16
13F-HR2023-08-11
SC 13D/A2023-08-03

View Velan Capital Investment Management LP's complete filings history.

Export Velan Capital Investment Management LP's holdings